Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Finasteride for hair loss may cause gynecomastia; doctors should inform patients.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Azelaic acid and anthralin are similarly effective for treating patchy hair loss.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Scalp microneedling may improve hair density and thickness for various alopecia types.

Home-use cosmetic laser and light devices show modest results for hair removal and acne treatment, but more research is needed for confirmation.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.